PIRO, SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 7.363
EU - Europa 3.641
AS - Asia 2.348
AF - Africa 559
SA - Sud America 531
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.456
Nazione #
US - Stati Uniti d'America 7.119
IT - Italia 1.398
SG - Singapore 1.353
IE - Irlanda 911
CN - Cina 731
UA - Ucraina 581
BR - Brasile 493
CI - Costa d'Avorio 356
CA - Canada 232
RU - Federazione Russa 202
SN - Senegal 151
SE - Svezia 136
DE - Germania 135
VN - Vietnam 78
GB - Regno Unito 54
FI - Finlandia 39
FR - Francia 36
TR - Turchia 34
NG - Nigeria 32
UZ - Uzbekistan 32
NL - Olanda 31
AT - Austria 27
IN - India 27
CH - Svizzera 24
HK - Hong Kong 18
LB - Libano 14
GR - Grecia 12
AR - Argentina 11
BD - Bangladesh 9
BG - Bulgaria 9
JP - Giappone 9
MA - Marocco 9
PK - Pakistan 9
BE - Belgio 8
CZ - Repubblica Ceca 8
PL - Polonia 8
EC - Ecuador 7
AU - Australia 6
EU - Europa 6
IR - Iran 6
IQ - Iraq 5
MX - Messico 5
PY - Paraguay 5
VE - Venezuela 5
AZ - Azerbaigian 4
CL - Cile 4
DO - Repubblica Dominicana 4
RO - Romania 4
ZA - Sudafrica 4
CO - Colombia 3
KE - Kenya 3
AL - Albania 2
GE - Georgia 2
HU - Ungheria 2
IS - Islanda 2
KG - Kirghizistan 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
EE - Estonia 1
ES - Italia 1
GL - Groenlandia 1
GY - Guiana 1
ID - Indonesia 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SV - El Salvador 1
TG - Togo 1
TN - Tunisia 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 14.456
Città #
Santa Clara 1.286
Chandler 1.025
Dublin 910
Singapore 754
Jacksonville 641
Chicago 425
Boardman 363
Abidjan 356
Cambridge 247
Lawrence 246
Andover 245
Catania 217
Nanjing 216
Civitanova Marche 203
Toronto 182
Ashburn 172
Wilmington 159
Dakar 151
Des Moines 133
Milan 130
Rome 124
San Mateo 95
Padova 64
Dong Ket 63
Houston 63
Nanchang 63
Shenyang 60
Bremen 55
Hebei 53
Ottawa 44
Saint Petersburg 44
Beijing 42
Council Bluffs 42
Jiaxing 38
Changsha 36
Abuja 32
Los Angeles 31
Palermo 30
Munich 27
São Paulo 27
Moscow 24
Seattle 24
Tianjin 24
Carrara 22
Lappeenranta 21
Messina 20
Boydton 19
Istanbul 19
Helsinki 18
Washington 17
Belo Horizonte 16
Pune 16
Hanoi 15
Hong Kong 15
Rio de Janeiro 15
The Dalles 14
Jinan 11
Norwalk 11
Tashkent 11
Bari 10
Brasília 10
Den Haag 10
San Francisco 10
Augusta 9
Leawood 9
Reggio Emilia 9
Taizhou 9
Woodbridge 9
Ann Arbor 8
Cascina 8
Gravina di Catania 8
Guangzhou 8
Tokyo 8
Campo Grande 7
Edinburgh 7
Falls Church 7
Grafing 7
Hangzhou 7
Mountain View 7
Ningbo 7
Pollenza 7
Salvador 7
Belpasso 6
Enna 6
Frankfurt Am Main 6
Frankfurt am Main 6
Goiânia 6
Guarulhos 6
Kunming 6
Liberty Lake 6
Naples 6
Redwood City 6
San Giovanni la Punta 6
São Bernardo do Campo 6
Vienna 6
Alvorada 5
Amsterdam 5
Betim 5
Brno 5
Campinas 5
Totale 9.717
Nome #
IL DIABETE MELLITO AUMENTA LE RESISTENZE ARTERIOSE RENALI NEI PAZIENTI CON CIRROSI EPATICA 685
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 140
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 128
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 102
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 102
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 100
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 97
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 91
Antibiotic use and associated factors in a large sample of hospitalised older people 90
Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. 89
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 86
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 86
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 86
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 84
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 83
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 83
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery 82
Funzione mitocondriale in isole pancreatiche di pazienti con diabete tipo 2 82
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 82
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 81
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. 81
An Uncharacterised lncRNA Coded by the ASAP1 Locus Is Downregulated in Serum of Type 2 Diabetes Mellitus Patients 79
Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction 79
Chronic Exposure to GLP-1 Increases GLP-1 Synthesis and Release in a Pancreatic Alpha Cell Line (α-TC1): Evidence of a Direct Effect of GLP-1 on Pancreatic Alpha Cells 78
L’induzione di apoptosi da parte di protoni suggerisce innovative strategie terapeutiche anticancro 78
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 78
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 78
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 77
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 77
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 77
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 76
Candidate genes of SARS-CoV-2 gender susceptibility 76
Effetti della glucotossicita' su una linea cellulare di L cellule intestinali (GLUTAg: Ruolo di UCP-2 75
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 75
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 75
LONG NON-CODING RNA ASSOCIATI AL DIABETE MELLITO. FOCUS SULLE COMPLICANZE MICRO E MACROVASCOLARI 75
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 75
(2012). Specifically different microRNAs profiles provide new insights on the molecular mechanisms activated by cytotoxic proinflammatory cytokines in mammalian pancreatic alpha and beta cells 74
Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy 74
Role of ATP Production and Uncoupling Protein-2 in the Insulin Secretory Defect Induced by Chronic Exposure to High Glucose or Free Fatty Acids and Effects of Peroxisome Proliferator-Activated Receptor-gamma Inhibition 74
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 74
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 73
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 73
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting 73
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 72
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 72
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 72
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 72
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 71
Glucagon as a therapeutic approach to severe hypoglycemia: After 100 years, is it still the antidote of insulin? 71
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 71
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 71
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 70
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery (AM) 69
Chronic exposure to high leucine impairs glucose-induced insulin release by lowering the ATP to ADP ratio 68
Chronic exposure to palmitate affects insulin signaling in pancreatic alpha cells 68
Clinical and molecular biomarkers for diagnosis and staging of nafld 68
Heart failure and chronic kidney disease in a registry of internal medicine wards 68
Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients 67
Type 2 diabetes susceptibility gene expression in normal or diabetic sorted human alpha and beta cells: correlations with age or BMI of islet donors 67
Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta cells 67
Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus. 67
Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 66
296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells 66
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 66
miR-296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells 66
Il GLP-1 migliora il segnale insulinico intracellulare in una linea di alfa cellule pancreatiche murine (a-TC1-6) 64
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFLD 64
A molecular systems biomedicine approach to Diabetes: characterization, prioritization and network analysis of new candidate genes from the apoptotic machinery 64
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 64
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 64
Exposure to glibenclamide increases rat beta cell sensitivity to glucose 63
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFDL 63
Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications 63
Role of ATP production and uncoupling protein 2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids 62
L'emoglobina Glicosilata potrebbe identificare soggetti con normale tolleranza al glucosio ma con alterazione dei markers precoci di danno cardiovascolare. 62
Alterazioni molecolari del segnale insulinico e del metabolismo degli FFA in pazienti con NASH 62
Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects 61
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity. 61
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 61
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 60
Thyroid Cancer and Circadian Clock Disruption 60
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 60
Soggetti obesi insulino- resistenti con elevato rischio per diabete tipo 2 mostrano disfunzione alfa- cellulare ed alterata secrezione di GLP-1 comparati a individui obesi metabolicamenti sani 59
• Effect of metabolic sindrome and altered glucose tolerance on distolic cardiac function and intima-media thickness.• Effect of metabolic sindrome and altered glucose tolerance on distolic cardiac function and intima-media thickness 59
Chronic exposure to high glucose or free fatty acids impairs insulin secretion by increasing uncoupling-2 protein (UCP-2) expression and affecting glucose metabolism 59
La lipotossicità peggiora il segnale insulinico intracellulare in una linea di L-cellule intestinali murine (GLUTag) 59
Insulin secretory function is impaired in isolated human islets carrying the Gly972-Arg IRS-1 polymorphism 59
Prediabete: Criteri diagnostici e rischio cardiovascolare 59
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 58
Incretin-based therapies: a focus on alpha cells and glucagon secretion. 58
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people 58
Gli incretinomimetici e gli inibitori del DPP-IV 58
Palmitate affects insulin receptor phosphorylation and intracellular insulin signal in a pancreatic alpha-cell line 58
Therapeutic options for elderly diabetic subjects: open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs 58
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 58
Effects of fatty acids on beta-cell survival. 57
Incretin axis activation could be responsible for hyperinsulinemia of normotolerant subjects affected by metabolic syndrome 57
Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis. 57
Deregolazione del miRNoma intracellulare ed extracellulare ed analisi bioinformatica in modelli in vitro di NAFLD e NASH 57
Totale 7.844
Categoria #
all - tutte 57.622
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.622


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020173 0 0 0 0 0 0 0 0 0 0 115 58
2020/20211.254 12 106 139 20 328 37 155 9 96 91 156 105
2021/20221.861 190 257 9 37 314 55 272 71 146 9 61 440
2022/20233.094 262 156 47 313 281 511 10 601 718 19 112 64
2023/20241.465 68 236 74 72 68 313 48 133 17 38 227 171
2024/20255.525 697 863 326 421 1.183 646 242 221 378 543 5 0
Totale 14.906